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Mycobacterium tuberculosis (M.tb), the pathogen responsible for tuberculosis (tB) poses as the major 
cause of death among infectious diseases. the knowledge about the molecular diversity of M.tb 
enables the implementation of more effective surveillance and control measures and, nowadays, 
Whole Genome Sequencing (WGS) holds the potential to produce high-resolution epidemiological 
data in a high-throughput manner. florianópolis, the state capital of Santa catarina (Sc) in south 
Brazil, shows a high TB incidence (46.0/100,000). Here we carried out a WGS-based evaluation of the 
M.tb strain diversity, drug-resistance and ongoing transmission in the capital metropolitan region. 
Resistance to isoniazid, rifampicin, streptomycin was identified respectively in 4.0% (n = 6), 2.0% 
(n = 3) and 1.3% (n = 2) of the 151 studied strains by WGS. Besides, resistance to pyrazinamide and 
ethambutol was detected in 0.7% (n = 1) and reistance to ethionamide and fluoroquinolone (FQ) in 
1.3% (n = 2), while a single (0.7%) multidrug-resistant (MDR) strain was identified. SNP-based typing 
classified all isolates into M.tb Lineage 4, with high proportion of sublineages LAM (60.3%), T (16.4%) 
and Haarlem (7.9%). The average core-genome distance between isolates was 420.3 SNPs, with 43.7% 
of all isolates grouped across 22 genomic clusters thereby showing the presence of important ongoing 
tB transmission events. Most clusters were geographically distributed across the study setting which 
highlights the need for an urgent interruption of these large transmission chains. the data conveyed 
by this study shows the presence of important and uncontrolled tB transmission in the metropolitan 
area and provides precise data to support tB control measures in this region.
Tuberculosis (TB) remains a major public health threat and is currently the tenth leading cause of death world-
wide and the leading cause of death by a single infectious microorganism. In 2018, 1.5 million people died from 
TB and 10 million new cases are estimated to have occurred worldwide. Brazil, along with the Russian Federa-
tion, India, China and South Africa—the BRICS countries—account for more than 40% of the global TB disease 
burden in incidence and deaths, and about 58% of the global burden of drug-resistant TB. In Brazil, 90,527 TB 
cases were reported (45 per 100,000 population) in  20181. While the state of Santa Catarina in Southern Brazil is 
characterized by an intermediate TB incidence rate—23.7 per 100,000 population, the state capital Florianópolis 
shows a higher incidence rate of 46.0 per 100,000 population along with high rates of TB-HIV co-infection2.
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Worldwide, the asymmetrical distribution of the disease is also linked with distinctive lineages and genotypes 
of the Mycobacterium tuberculosis (M.tb) Complex species, the etiological agent of  TB3. Early strain typing meth-
ods greatly boosted our understanding of TB transmission dynamics while simultaneously providing additional 
tools and perspectives on the phylogeographic landscape of such strains at a global  level3. These so-called classical 
typing methods, i.e., those based on the characterization of genetic repetitive elements, have been successful in 
informing public health interventions due to the inability of traditional contact tracing approaches to reconstruct 
complex transmission  chains4–6. In fact, population-based typing of M.tb clinical isolates has been important to 
infer on the degree of recent infection and highly relevant in the identification of specific risk factors and geo-
spatial hotspots for intensified TB transmission. Two classical examples of such studies are those conducted in 
San Francisco and New York in the late 1980s and early 1990s that enabled the correlation of specific ethnicities, 
drug resistance and/or residence in specific areas with recent TB transmission as assessed by genetic clustering 
based on profiles obtained with Restriction Fragment Length Polymorphisms with IS61106,7. In the next decades, 
classical genotyping methods such as Spoligotyping and Mycobacterial Interspersed Repetitive Unit—Variable 
Number of Tandem Repeat (MIRU-VNTR) have been widely used for molecular epidemiology  studies8. While 
these methods have been an integral part of several national TB control plans, most of the genomic diversity 
and distinctiveness of each isolate is overlooked by typing methods that are only able to interrogate a minor 
fraction of an isolate’s  genome9–11. In contrast, Whole Genome Sequencing (WGS) has emerged as the leading 
typing strategy to study the dissemination and transmission dynamics at a genome-wide SNP-based resolution 
that clearly outperforms classical typing methods and, coupled with molecular evolutionary approaches, also 
holds the potential to retrace the evolutionary history of locally circulating  strains12,13. This level of resolution 
has enabled the reconstruction of the microevolutionary trajectory of circulating extensively drug resistant 
strains in Portugal and South Africa along with the breakdown into genomic clusters that are proposed to reflect 
epidemiological links between  patients14–16.
In Santa Catarina state, in Brazil, it is known that the M.tb population structure is mostly dominated by Latin 
American and Mediterranean (LAM) strains, followed by the “ill-defined” T strains as assessed by  spoligotyping17. 
However, nothing is known regarding the genomic diversity associated with this region and reports using higher 
resolution typing methods are limited to 12-loci MIRU-VNTR18. To address this gap, herein we report the 
preliminary results from a genomic epidemiological study in the metropolitan area, aiming to unravel the M.tb 
genotypes circulating in this region, infer on existing and active transmission clusters in the community, and 
examine the distribution of drug resistance while exploring possible associations between unfavorable treatment 
outcomes and SNP-based lineages.
Results
Study sample and epidemiology. The study encompasses 151 patients diagnosed with TB that started 
on anti-TB treatment between May 2014 and May 2016 in the metropolitan area. Ninety-six (63.6%) patients 
were male and 49% of all patients were aged between 26 and 45 years. Regarding the risk factors and comorbidi-
ties, 13 (8.6%) patients had diabetes mellitus, 47 (31.1%) had alcohol abuse history, 85 (56.3%) were tobacco 
users and 47 (31.1%) illicit drug users. Twenty-seven (17.9%) patients were co-infected with human immuno-
deficiency virus (HIV) (Supplementary Table S1). In addition, nine (6.0%) individuals were homeless and four 
(2.6%) spent time in a prison establishment.
Drug resistance and molecular basis. Among the 151 isolates obtained for the study, genotypic-based 
prediction for drug resistance enabled the identification of six (4.0%) isoniazid resistant isolates, three (2.0%) 
with rifampicin resistance, two (1.3%) streptomycin resistant isolates and, resistance to pyrazinamide and eth-
ambutol was detected in one isolate (0.7%). Besides, resistance to second-line drugs were detected for ethiona-
mide (n = 2; 1.3%) and for the FQ (n = 2; 1.3%). One MDR isolate was identified (Fig. 1).
The detected mutations underpinning these genotypic-based predictions are listed in Table 1 with the 
Ser315Thr at the katG gene being the most frequent mutation associated with isoniazid resistance (n = 4/6; 
66.7%). Two additional inhA promoter mutations (inhA C-15T and T-8C) were putatively associated with isonia-
zid resistance and ethionamide resistance. Resistance to rifampicin was driven by two distinct rpoB mutations: 
Ser450Leu (n = 2; 1.3%) and Ser441Leu (n = 1; 0.7%). Two putative compensatory mutations were detected in 
the single MDR isolate found: ahpC − 48G>A and rpoC  Phe452Ser19. The complete resistance-related mutation 
profile of all isolates is shown in the Supplementary spreadsheet.
Genomic population structure and phylogeny. All strains had been previously characterized by clas-
sical spoligotyping by membrane reverse-hybridization methods, revealing a population structure composed 
mainly of LAM strains (n = 91; 60.3%), followed by the ill-defined T strains (n = 25; 16.4%) and Haarlem (n = 12; 
7.9%). In total, 38 different SITs were found; the SIT 216/LAM5 (13.2%) was the most prevalent, followed by 
SIT 42/LAM9 (7.3%), SIT 17/LAM2 (7.3%) and SIT 64/LAM6 (7.3%) (Fig. 1). As all clinical isolates were sub-
sequently subjected to WGS, and consistent with the spoligotyping-based classification, all 151 isolates were 
classified as M.tb Lineage 4 (Euro-American) across 13 of its sub-lineages with sub-lineages 4.3.3 (30.5%), 4.3.4.1 
(19.9%) and 4.3.4.2 (13.2%) being the most frequent. Moreover, screening for the fbpC103 SNP marker for LAM 
confirmed the spoligotyping-based classification of all LAM strains while three isolates initially classified as 
belonging to the T family were found to bare fbpC103 and, from a phylogenetic standpoint, should therefore be 
considered as LAM strains (SC61, SC115, SC134 [SIT823/T1]). Eleven additional isolates without clade assign-
ment or of unknown profile on SITVIT2 also carry this marker (ten Orphans and one SIT2752) (Fig. 1). A 
genome-wide phylogeny based on 17,027 core SNPs displayed a topology congruent with the distribution of the 
different sub-lineages found where the LAM strains herein assessed based on the fbpC103 polymorphism formed 
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Figure 1.  Maximum likelihood phylogenetic tree for the 151 M.tb isolates included in the study. This tree was 
constructed based on 17,027 core SNPs and is shown annotated with (from the outside to the inside): presence 
or absence of fbpC103 LAM marker; SIT and spoligotyping clade; SNP-based sub-lineage; drug resistance 
associated mutations; and genotypic-based prediction for drug susceptibility. Tips are shown coloured according 
to the genomic cluster (see legend). NC not clustered, GC genomic cluster.
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a deeply rooted monophyletic clade. All drug resistant isolates detected were scattered across the phylogenetic 
tree suggesting independent emergence of drug resistance associated mutations.
Snp-based clustering and M.tb transmission. The average distance amid the core-genome of the 
151 isolates was 420.3 SNPs. To delineate genomic clusters that might reflect recent transmission underpinned 
by putative epidemiologically linked patients, isolates within a maximum distance of 5 SNPs were assigned to 
genomic clusters (GC). Using this cutoff criterion, a total of 66 (43.7%) isolates were grouped into 22 clusters. 
The largest cluster (GC1) involved 12 isolates including one isolate obtained from a patient that spent time 
in a prison. The second largest cluster (GC3) involved six patients while the third largest clusters (GC14 and 
GC4) included four isolates each; GC14 with one isolate from an individual with incarceration history and GC4 
including two epidemiologically-linked patients that shared the same household (pairwise distance: 0 SNPs). 
The remaining 18 genomic clusters included 42 isolates: one cluster included one isolate from an individual that 
spent time in a prison establishment; another cluster included a homeless patient; and, one other cluster was 
composed of two household contacts (pairwise distance: 0 SNPs; Supplementary Table S2). All clusters except 
GC1, GC8 and GC22 formed monophyletic branches in the phylogenetic tree suggesting further circulation and 
differentiation of strains within the same branch. The GC2 branch stemmed from within the GC1 clade. GC5 
(n = 2) and GC22 (n = 2) isolate appear to have emerged from a broader late-branching phylogenetic SIT73/T 
(sub-lineage 4.1.2) clade that may represent a group of a mostly non-clustered strain that underwent extensive 
circulation in the community. A minimum spanning tree (MST) obtained for all isolates confirmed the integrity 
of all clusters highlighting a more extensive dissemination of GC1 isolates along with the observation of inde-
pendently generated drug resistance associated nodes in the tree (Fig. 2, Supplementary Figure S1).
In the present sampling, the geographical distribution of patients across metropolitan region by residence 
location showed a higher concentration of cases among patients living at the central region of Florianópolis. 
Nevertheless, genome clustered cases did not show any particular pattern of geographical clustering as patients 
whose isolates were clustered showed a wide geographical dispersion in the studied region (Fig. 3). Comparing 
the pairwise geographic distances between patients’ residence (Fig. 3, Supplementary Figure S2) no statistically 
significant difference was observed between non-clustered patients (average pairwise distance: 13.7 km; range 
0–45 km) and patients within the seven largest clusters (n ≥ 3 patients) except for: patients in GC2 (average 
pairwise distance: 3.7 km; range 1–5 km) which showed a statistically lower pairwise distance (p = 0.0302, Wil-
coxon Rank Sum Test); patients in GC4 (average pairwise distance: 2.2 km; range 0–5 km) which also showed a 
statistically lower average pairwise geographic distance (p = 0.0004, Wilcoxon Rank Sum Test); and, likewise for 
patients in GC10 (average pairwise distance: 2.2 km; range 0–5 km; p = 0.0004, Wilcoxon Rank Sum Test). The 
geographical distribution of the analysed cases is similar to the 263 cases reported for Greater Florianópolis in 
the same period (Supplementary Figure S3).
treatment outcome and statistical association. According to the data collected, 107 (70.9%) patients 
were declared cured, treatment failure occurred in four (2.6%) patients and six (4.0%) patients died. Addition-
ally, treatment dropout was observed for 33 (21.9%) patients and no information on the treatment outcome was 
available for one (0.7%) patient (Table1).
We found a statistically significant association between TB outcome and HIV coinfection (p = 0.022, Fisher’s 
exact Test) since the coinfected patients had a statistically lower cure rate (75% vs 94.5%, respectively) and a 
higher death rate (18.7% vs 2.2%, respectively). No statistical association between TB outcome and the others 
risk factors (alcohol intake, illicit drugs usage and clustering) was found (p ≥ 0.05; Table 2).
Regarding treatment dropout and risk factors, we found that: higher treatment dropout rates were statis-
tically associated with excessive alcohol intake (p = 0.009, Chi-square Test) and HIV coinfection (p = 0.009, 
Chi-square Test); HIV coinfection was associated with illicit drug usage (p ≤ 0.001, Chi-square Test), alcohol 
Table 1.  Mutations detected in genes associated with drug resistance across the 151 M.tb isolates included in 
the study.
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intake (p ≤ 0.001, Chi-square test) and lower rates of hemoptysis (p = 0.011, Chi-square Test; Table 2). Illicit drug 
usage and excessive alcohol intake were also found to be associated (p ≤ 0.001, Chi-square Test). No statistically 
significant association was found between clinical characteristics and SNP-based M.tb lineages. We tested also 
the hypothesis of a possible association between the outcomes and/or clinical characteristics and clustering, 
however, no association was found. Likewise, no significant association was found between risk factors and 
clustering (data not showed).
Figure 2.  Minimum spanning tree (MST) of the 151 M.tb clinical isolates included in the present study. This 
MST is based on 17,027 core SNPs and nodes are shown coloured in function of the associated genomic cluster.
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Discussion
This study evaluates the scenario of M.tb strain diversity between May-2014 and May-2016, analyzing individu-
als from the metropolitan region of Florianópolis diagnosed with pulmonary TB at Florianópolis and São José 
(the two most populous of the 22 cities that comprise the metropolitan region of Florianópolis). Despite the 
importance of knowing the molecular profile of circulating M.tb strains in a given setting, the existing data for 
this particular region is limited to the classical genotypic characterization of circulating  strains17,18,20. The pre-
sent study comprises the first genome-wide study on M.tb in Santa Catarina state. Greater Florianópolis has a 
higher TB incidence when compared to the overall incidence rate on the state level, an intermediate prevalence 
 setting21. In this study sample we found a high rate of TB-HIV co-infection (19.71%) that is consistent with 
the rate expected for this region (22.6%) and is well above the national rate (9.4%)22. Co-infected patients were 
associated with a low cure rate and excessive consumption of alcohol and drugs. HIV-coinfection is a widely 
known risk factor for TB development since the risk for TB development is 19 times higher in the population 
living with HIV when compared with the rest of the population, leading to poorer outcomes and lower relapse-
free cure  rates1,23. Nonetheless, alcohol abuse or unhealthy alcohol usage is an increasingly acknowledged risk 
factor known to affect the outcome of TB treatment and a risk factor for TB treatment  adherence24,25. Recent data 
obtained in Uganda and Kenya further demonstrate that alcohol use among HIV-infected individuals appears 
Figure 3.  Geographic distribution of 142 out of the 151 TB cases (excluding 9 homeless) included in the 
study for which address of residence was available. These cases were geographically mapped according to the 
respective address of residence and are shown in the map colored according to the respective isolate’s genomic 
cluster. The spatial distribution of these cases and correlation with the genomic cluster shows an extensive 
geographical spread of the larger clusters (n ≥ 3) except for GC2, GC4 and GC10. The map was created using the 
online microreact tool, available at https ://micro react .org/proje ct/hrdK7 GcztX 8M2ZX EXjc5 79.
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to be associated with decreased viral suppression due to the lower diagnosis rate and lower likelihood of being 
on an anti-retroviral treatment regimen if already HIV  diagnosed26. In this regard, an integrated approach to 
reduce unhealthy alcohol consumption or illicit drug usage may lead to better  outcomes27.
WGS data enabled the screening of drug-resistance conferring mutations on a genome-wide scale which 
allowed the identification of 10 (6.6%) isolates resistant to at least one anti-TB drug and one (0.7%) MDR-
TB isolate. Despite the low MDR-TB rate in this study, two clinical isolates from different patients are pre-
dicted to be mono-resistant to the FQs due to two distinct high-confidence gyrA mutations for FQs resistance 
 prediction16,28. FQ mono-resistance or among non-MDR isolates has been reported across multiple settings with 
varying  ranges29. Recently Kim et al.30 reported a 0.8% FQ resistance rate among non-MDR strains detected 
across multiple hospitals in South Korea while revealing an increasing trend over the last two decades. TB patients 
with prior FQ prescription to TB diagnosis, usually to treat community-acquired pneumonia, have a three-fold 
higher risk of having FQ-resistant  TB31. Multiple FQ prescriptions, FQ prescription more than 60 days prior 
for TB diagnosis and for more than 10 days are associated with FQ-resistant  TB31,32. This study shows a 1.3% 
FQ-resistance rate among non-MDR-TB patients for this setting driven by two independent mutational events. 
One limitation to the interpretation of the data lies in the fact that no data regarding previous FQ exposure was 
obtained for these two patients and, as such, we cannot exclude these from being primary FQ mono-resistant 
TB  cases33. Nonetheless, the detection of these two FQ mono-resistant isolates warns against a possible exces-
sive usage of FQs in the community and calls upon additional antimicrobial stewardship measures since to our 
knowledge these comprise the first two FQ mono-resistance cases to be reported in Brazil.
Regarding M.tb diversity, SNP-based typing classified all the 151 isolates as Euro-American lineage 4 strains. 
The Euro-American lineage predominance in Santa Catarina State and in the Southern  Brazil17,34, occurred due 
to migratory processes from Europe to South America that increased in the seventeenth  century35. Therefore, 
LAM, T and Haarlem, the most common spoligotyping families identified in this study, were also found in 
other studies in Southern  Brazil17,20,34,36,37. Our examination of the distribution of the  fbpC103 SNP, considered 
as a highly specific marker for the LAM family not only confirmed the identification of all spoligotyping-based 
identified LAM, but increased the frequency of this lineage to 69.5% (105/151). The three SIT823/T1 isolates, 
assigned to the “ill-defined” T family according to SITVIT2 are in fact phylogenetically positioned as LAM in 
the phylogenetic tree.
In accordance with previous  studies38,39, using a conservative five-SNP threshold to define genomic transmis-
sion clusters enabled the clustering of 43.7% of the isolates included in the study thereby demonstrating that 
approximately half of the TB cases in metropolitan region between 2014 and 2016 were due to recent transmis-
sion. One recent epidemiological transmission study conducted in the Pará State, in North Brazil, across house-
hold contacts did find two cases in the same household whose isolates are described as being 9 SNPs  apart40. 
In this latter study, the route of transmission is unclear since the temporal distance between these isolates was 
7 years and therefore questions if the transmission between these cases was direct and, if missing links are likely 
to exist. Herein, we opted to use a 5 SNP distance cutoff as to obtain high-confidence genomic clusters that are 
driven by recent transmission. Also, no association was found between clustering and risk factors, treatment 
dropout and clinical characteristics when using 12 or 25 SNPs cutoff distances to define clusters (data not shown).
The recent transmission scenario herein obtained lends support to a continued TB transmission, most likely 
still ongoing. A limitation to the study relies in the fact that only 151 (57.4%) cases were analyzed from a total 
of 263 reported cases for the same period in Greater Florianópolis and missing links in transmission chains are 
therefore likely to exist. However, the data conveyed has already enabled the detection of one large transmission 
cluster (GC1) that is responsible for 7.9% of the cases analyzed. All the isolates grouped into GC1 belonged to 
M.tb sublineage 4.3.3 and to SIT216/LAM5. Interestingly, SIT216/LAM5 has been described in Santa Catarina 
Table 2.  Risk factors associated with TB outcome, treatment dropout and hemoptysis. Statistically significant 
associations are highlighted in bold.
Risk factor
TB outcome Treatment dropout Hemoptysis
Death Cure
Treatment 
failure Total p No Yes Total p No Yes Total p
Alcohol intake
No 3 (4.9%) 55 (90.2%) 3 (4.9%) 61 61 (83.6%) 12 (16.4%) 73 44 (63.8%) 25 (36.2%) 69
Moderate 0 (0.0%) 23 (100.0%) 0 (0.0%) 23 0.230 23 (85.2%) 4 (14.8%) 27 0.009 17 (63.0%) 10 (37.0%) 27 0.813
Excessive 3 (13.6%) 18 (81.8%) 1 (4.6%) 22 22 (59.5%) 15 (40.5%) 37 23 (69.7%) 10 (30.3%) 33
HIV coinfection
Pos 3 (18.7%) 12 (75%) 1 (6.3%) 16 0.022 16 (59.3%) 11 (40.7%) 27 0.009 21 (87.5%) 3 (12.5%) 24 0.011
Neg 2 (2.2%) 85 (94.5%) 3 (3.3%) 90 90 (82.6%) 19 (17.4%) 109 63 (60.0%) 42 (40.0%) 105
Illicit drug usage
Yes 2 (8.3%) 22 (91.7%) 0 (0.0%) 24 0.464 24 (51.1%) 23 (48.9%) 47 0.000 32 (71.1%) 13 (28.9%) 45 0.290
No 3 (3.7%) 73 (91.3%) 4 (5.0%) 80 80 (90.9%) 8 (9.1%) 88 50 (61.7%) 31 (38.3%) 81
Clustering
Yes 2 (3.9%) 46 (90.2%) 3 (5.9%) 51 0.391 51 (78.5%) 14 (21.5%) 65 0.905 42 (66.7%) 21 (33.3%) 63 0.830
No 4 (6.1%) 61 (92.4%) 1 (1.5%) 66 66 (77.6%) 19 (22.4%) 85 50 (64.9%) 27 (35.1%) 77
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state as the most prevalent SIT in prison establishments but only one isolate in GC1 had spent time in  prison18. 
These facts highlight the epidemiological importance of SIT216/LAM5 clones, now at the community level, 
and its association with recent transmission. LAM5 spoligotype is also the most reported in Rio Grande do 
Sul, another state in Southern Brazil, however belonging to  SIT9334. A parallel situation has been reported with 
SIT863 MDR-TB strains in Rio Grande do Sul, that was initially identified in prison establishments but is now 
responsible for the majority of MDR-TB cases in that  state37,41. The presence of isolates from inmate individuals 
in the TB transmission chains supports the dissemination of strains between the general population and prison 
establishments and although the directionality is unclear at this point, the latter along with the entire prison 
system may act as reservoir of specific strains and promote a wider dispersion of specific  clones42. Herein, the 
GC1 cluster showed a widespread geographical distribution when patient residence is considered (Supplementary 
Figure S2). Additionally, the low core-genome SNP distances among the isolates in these largest genomic clusters, 
may indicate that transmission has occurred in a very recent timeframe and is likely ongoing, suggesting that 
in order to prevent further spread of these strains, closer surveillance of these phylogenetically distinct clades 
is highly important.
Here we conducted the first WGS-based M.tb diversity study in SC state. Our study has some limitation, 
among them, for several samples phenotypic DST were not available, thus, we used WGS data to drug resistance 
prediction. Besides that, the present study only included new TB cases that started a first-line anti-TB treatment. 
Although the sampling in the present study occurred from 2014 to 2016, more recent data show an increase in the 
incidence TB rate (43.5% in 2016–46.0% in 2018)2,22 and it would be interesting to evaluate if this is due to strains 
belonging to the main transmission chains herein identified. This fact reinforces the importance of molecular 
epidemiology as an instrument for TB surveillance and supporting public health measures.
conclusions
The present study stresses the importance of WGS-based approaches that enable high-resolution phylogenetic 
analysis to investigate M.tb transmission in Brazil and when compared with classical genotyping techniques that 
may lead to overestimated clustering  rates43. In this study we undertook a WGS-based analysis of the genetic 
diversity and recent M.tb transmission in a Southern Brazil region improving the knowledge about TB dynamics 
in this setting and filling out the lack of genomic data on M.tb strains circulating in the state of Santa Catarina. 
The data shows that uncontrolled TB transmission in the metropolitan region of Florianópolis occurred and 
provides precise data to support TB control measures in this region.
Materials and methods
Study design and population. A total of 151 M.tb complex strains obtained in the Central Laboratory of 
the State of Santa Catarina (LACEN), the reference laboratory for TB diagnosis in Santa Catarina were included 
in this study. The samples were from patients with bacteriological confirmation of pulmonary TB, diagnosed 
in health units at Florianópolis and São José cities (Florianópolis metropolitan region) within a 2-year period 
(May-2014–May-2016). The study included individuals that started the first-line anti-TB treatment and patients 
that met the inclusion criteria and agreed to participate were invited to sign the informed consent. Patient enroll-
ment and medical record review were carried out in health units (Hospital Universitário da Universidade Fed-
eral de Santa Catarina and primary health units from Florianópolis and a specialized outpatient clinic respon-
sible for TB care in São José city), and an additional epidemiological questionnaire was applied in an interview. 
Patients with previous anti-TB treatment history were excluded from the study.
The estimated population in the both cities is 700,000  inhabitants44 and the TB incidence rate approximately 
46 cases per 100,000  population21. During the study period, a total of 263 new pulmonary TB cases with positive 
culture were notified, of these, 218 were able to contact and accepted to participate in the study; 151 had DNA 
available for sequencing, representing 57.4% of the total (Supplementary Table S3). Mycobacterium tuberculosis 
was isolated from sputum samples obtained from patients before starting anti-TB treatment. The treatment 
outcomes were assessed upon treatment completion and defined as cure, treatment failure (persistence of smear 
microscopy and/or culture positives after the treatment), treatment dropout or death.
Smear microscopy and culture. The smear microscopy and Ziehl–Neelsen method were performed at 
the Central Laboratory of the State of Santa Catarina (LACEN), the reference laboratory for TB diagnosis in 
Santa Catarina according to the recommendations of the Recommendations Manual for TB control in  Brazil45. 
Isolation M.tb complex was performed in Ogawa–Kudoh solid media according to the same  Manual45. The 
identification to the M.tb complex level was carried by the presence of the cord factor and by MPT64 protein 
detection-based immunochromatographic test (SD Bioline Kit, Standard Diagnostics, Inc., Korea).
DnA extraction. The M.tb nucleic acids were extracted from mycobacterial cultures grown on Ogawa–
Kudoh solid medium using the Cetyltrimethylammonium Bromide (CTAB) method, as described by van 
Soolingen et al.46, at the Laboratory of Molecular Biology, Microbiology and Serology (LBMMS)-UFSC.
Spoligotyping. Spoligotyping was carried out as described by Kamerbeek et al.9 using commercially pre-
pared membrane (Ocimum Biosolutions, Hyderabad, Telangana, India). Hybridizing fragments were detected 
by chemiluminescence using peroxidase-labelled streptavidin and ECL detection kit (Amersham Biosciences, 
Amersham, Buckinghamshire, England, UK). The spoligotypes were classified according to the Spoligotyping 
International Type (SIT) and families, based on SITVIT2 database (https ://www.paste ur-guade loupe .fr:8081/
SITVI T2/). The technique was performed by Scheffer during doctoral  thesis47.
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Whole genome sequencing (WGS). The M.tb genomic DNA of 151 clinical strains was submitted to 
WGS. Approximately one microgram of DNA was fragmented using a Q800R2 sonicator (QSonica, Newtown, 
CT, USA) with the following parameters: 3 min sonication with 15 s pulse on, 15 s pulse off and 20% amplitude. 
The fragmented DNA was selected by size to target 600–700 bp by fragment separation using the Agencourt 
AMPure XP beads (Beckman Coulter, Code A63882). DNA Library preparation was performed using the NEB-
Next Ultra II DNA Library Prep Kit for Illumina (New England BioLabs, Code E7645L). The adapters and 8 bp 
index oligos based on Kozarewa and  Turner48 were purchased from IDT (Integrated DNA Technologies, San 
Diego, CA, USA) and used in place of those supplied in the NEB preparation kit in a dual-indexing  approach49. 
Paired-end sequencing (2 × 150 bp) was performed on a NextSeq sequencer from Illumina using either a 300 
cycle v2 mid output or high output kit (Illumina, Code FC-404-2003 or Code FC-404-2004) using standard 
Illumina procedure.
Bioinformatics analysis. Bioinformatic analysis of raw sequence reads was carried out initially using an 
in-house pipeline for genome-wide variant calling. Raw reads were trimmed to remove adapter sequences and 
low quality reads using Trimmomatic (v0.33) (parameters: LEADING:3 TRAILING:3 SLIDINGWINDOW:4:20 
MINLEN:36)50 and the read quality control was performed using FastQC (v0.11.7) (https ://www.bioin forma 
tics.babra ham.ac.uk/proje cts/fastq c/). Trimmed reads were mapped to the M.tb H37Rv reference genome (Gen-
Bank accession number: NC_000962.3) using BWA-MEM (v0.7.16). Samtools (v1.9)51 was used to convert from 
SAM to BAM format and sorting of mapped sequences. The quality of the resulting BAM file was checked using 
Qualimap52 and Sambamba (v0.6.8) was used to mark read  duplicates53. Variants (SNPs and small INDELs) were 
called using Samtools. Variants were filtered based on the following criteria: mapping quality ≥ 50, base align-
ment quality ≥ 23 and ≤ 2,000 reads covering each site. Variant functional annotation was performed with SnpEff 
(v4.3)54. WGS-based resistance prediction was performed using the command-line version of TB-Profiler55 
(v2.4), using the previously produced BAM files as input complementarily, VCF files were also screened for drug 
resistance associated variants and, if required, visually inspected in the BAM files. The definition of M.tb lineages 
based in SNP-typing method was performed according to the 62 SNPs barcode proposed by Coll et al.  201456 
and implemented in TB-Profiler. The fbpC103 polymorphism (G->A at codon 103) was used to differentiate LAM 
strains from non-LAM  strains57.
Phylogenetic analysis was performed using Snippy pipeline v4.3.6 (https ://githu b.com/tseem ann/snipp y) for 
variant calling and alignment of all core SNP variants. SNP positions within PE/PPE genes or other repetitive 
regions associated with low mappability scores were removed from the final core-genome alignment, which 
was composed of 17,027 positions. A maximum-likelihood phylogenetic tree was generated using the PhyML, 
applying the generalized time reversible (GTR) model and branch support assessed by the approximate Likeli-
hood Ratio Test (aLRT) as implemented in  Seaview58. The resulting tree was rooted using M. canettii (Genbank 
accession number: NC_019950.1). A minimum spanning tree was generated using Phyloviz (v2.0) and the 
therein implemented goeBURST  algorithm59. We used a 5, 12 and 25 SNPs cut-off to delineate genomic  clusters60 
among the core SNP alignment using R along with the ape package and the hclust function. The patient address 
was plotted in a map using the online tool Microreact (www.micro react .org). Pairwise geographical distances 
between patients were assessed in R using the Imap package.
Statistical analysis. We tested the possible association between TB outcome (favorable: cure or treatment 
completion versus unfavorable: treatment failure or death), treatment dropout and hemoptysis with the follow-
ing risk factors: alcohol intake, HIV coinfection, illicit drugs usage and clustering among the 151 individuals 
with available M.tb DNA. Besides, we tested the association among the risk factors. For this purpose, we applied 
the statistical tests Chi-square and Fisher’s exact Test performed in IBM SPSS Statistics v.26.
ethical approval. This study was approved by the Human Health Research Ethics Committee of Federal 
University of Santa Catarina (UFSC), protocol number: 2.054.560 CAAE: 66795917.1.0000.0121. Individuals 
who agreed to participate in the study signed the Informed Consent Term. The study was performed in accord-
ance with relevant guidelines and regulations.
Bio-containment measures. Diagnosis activities including cultures of clinical specimens of the M. tb 
complex and DNA extraction were carried out under Biosafety Level 2 (BSL-2) containment with BSL-3 safety 
equipment and work practices.
Data availability
Mycobacterium tuberculosis genome data were deposited in the NCBI BioProject ID PRJNA599957 (see Sup-
plementary spreadsheet).
Received: 9 April 2020; Accepted: 22 June 2020
References
 1. WHO. Global Tuberculosis Report 2019 (WHO, Geneva, 2019).
 2. Brasil. Ministério da Saúde. Ministério da Saúde. Departamento de Vigilância de Doenças Transmissíveis. Boletim Epidemiológico: 
Brasil Livre da Tuberculose: Evolução dos cenários epidemiológicos e operacionais da doença. (2019).
 3. Couvin, D., David, A., Zozio, T. & Rastogi, N. Macro-geographical specificities of the prevailing tuberculosis epidemic as seen 
through SITVIT2, an updated version of the Mycobacterium tuberculosis genotyping database. Infect. Genet. Evol. 72, 31–43 (2019).
10
Vol:.(1234567890)
Scientific RepoRtS |        (2020) 10:12891  | https://doi.org/10.1038/s41598-020-69755-9
www.nature.com/scientificreports/
 4. van Soolingen, D. et al. Molecular epidemiology of tuberculosis in The Netherlands: A nationwide study from 1993 through 1997. 
J. Infect. Dis. 180, 726–736 (1999).
 5. Golub, J. E. et al. Transmission of Mycobacterium tuberculosis through casual contact with an infectious case. Arch. Intern. Med. 
161, 2254–2258 (2001).
 6. Small, P. M. et al. The epidemiology of tuberculosis in san francisco: A population-based study using conventional and molecular 
methods. N. Engl. J. Med. 330, 1703–1709 (1994).
 7. Alland, D. et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic 
methods. N. Engl. J. Med. 330, 1710–1716 (1994).
 8. Gagneux, S. Current topics in microbiology and immunology. Curr. Top. Microbiol. Immunol. 374, 1–25 (2013).
 9. Kamerbeek, J. et al. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiol-
ogy. J. Clin. Microbiol. 35, 907–914 (1997).
 10. Van Embden, J. D. A. et al. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: Recommendations for a 
standardized methodology. J. Clin. Microbiol. 31, 406–409 (1993).
 11. Supply, P. et al. Proposal for standardization of optimized mycobacterial interspersed repetitive unit-variable-number tandem 
repeat typing of Mycobacterium tuberculosis. J. Clin. Microbiol. 44, 4498–4510 (2006).
 12. Kostoff, D. & Kendall, J. A quantitative evaluation ofMIRU-VNTR typing against whole-genome sequencing for identifying 
Mycobacterium tuberculosis transmission: A prospective observational cohort study. Genetica 13, 17–26 (2018).
 13. Meehan, C. J. et al. Whole genome sequencing of Mycobacterium tuberculosis: Current standards and open issues. Nat. Rev. Micro-
biol. https ://doi.org/10.1038/s4157 9-019-0214-5 (2019).
 14. Walker, T. M. et al. A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn 
of Africa: A molecular epidemiological study. Lancet. Infect. Dis. 18, 431–440 (2018).
 15. Cohen, K. A. et al. Evolution of extensively drug-resistant tuberculosis over four decades: Whole genome sequencing and dating 
analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal. PLoS Med. 12, 20 (2015).
 16. Perdigão, J. et al. Using genomics to understand the origin and dispersion of multidrug and extensively drug resistant tuberculosis 
in Portugal. Sci. Rep. 10, 2600 (2020).
 17. Nogueira, C. L. et al. First insight into the molecular epidemiology of Mycobacterium tuberculosis in Santa Catarina, southern 
Brazil. Tuberculosis 97, 57–64 (2016).
 18. Medeiros, T. F. et al. Molecular epidemiology of Mycobacterium tuberculosis strains from prison populations in Santa Catarina, 
Southern Brazil. Infect. Genet. Evol. 58, 34–39 (2018).
 19. Perdigão, J. & Portugal, I. Genetics and roadblocks of drug resistant tuberculosis. Infect. Genet. Evol. 72, 113–130 (2019).
 20. Prim, R. I. et al. xMolecular profiling of drug resistant isolates of Mycobacterium tuberculosis in the state of Santa Catarina, southern 
Brazil. Mem. Inst. Oswaldo Cruz 110, 618–623 (2015).
 21. Brasil. Ministério da Saúde. TabNet Win32 3.0: TUBERCULOSE—Casos confirmados notificados no Sistema de Informação de 
Agravos de Notificação-Brasil. https ://tabne t.datas us.gov.br/cgi/tabcg i.exe?sinan net/cnv/tuber cbr.def (2020).
 22. Brasil. Ministério da Saúde. Ministério da Saúde. Departamento de Vigilância de Doenças Transmissíveis. Boletim Epidemiológico: 
Indicadores prioritários para o monitoramento do Plano Nacional pelo Fim da Tuberculose como Problema de Saúde Pública no 
Brasil (2017).
 23. Magis-Escurra, C. et al. Treatment outcomes of MDR-TB and HIV co-infection in Europe. Eur. Respir. J. 49, 20 (2017).
 24. Fleming, M. F. et al. Alcohol and drug use disorders, HIV status and drug resistance in a sample of Russian TB patients. Int. J. 
Tuberc. Lung Dis. 10, 565–570 (2006).
 25. Chaves Torres, N. M., Quijano Rodríguez, J. J., Porras Andrade, P. S., Arriaga, M. B. & Netto, E. M. Factors predictive of the success 
of tuberculosis treatment: A systematic review with meta-analysis. PLoS One 14, e0226507 (2019).
 26. Puryear, S. B. et al. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based 
HIV testing in East Africa. AIDS 34, 405–413 (2020).
 27. Sandgren, A., Lonnroth, K., Piret, V., Pierpaolo, de C. & Aljona, K. Collaborative action on tuberculosis and alcohol abuse in 
Estonia First report of a demonstration project. WHO Reg. Off. Eur. (2013).
 28. Miotto, P. et al. A standardised method for interpreting the association between mutations and phenotypic drug resistance in 
Mycobacterium tuberculosis. Eur. Respir. J. 50, 20 (2017).
 29. Zignol, M. et al. Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: Results 
from a multicountry surveillance project. Lancet Infect. Dis. 16, 1185–1192 (2016).
 30. Kim, H. et al. Trend of multidrug and fluoroquinolone resistance in Mycobacterium tuberculosis isolates from 2010 to 2014 in 
Korea: A multicenter study. Korean J. Intern. Med. 34, 344–352 (2019).
 31. Devasia, R. A. et al. Fluoroquinolone resistance in Mycobacterium tuberculosis the effect of duration and timing of fluoroquinolone 
exposure. Am. J. Respir. Crit. Care Med. https ://doi.org/10.1164/rccm.20090 1-0146O C (2009).
 32. Long, R. et al. Empirical treatment of community-acquired pneumonia and the development of fluoroquinolone-resistant tuber-
culosis. Clin. Infect. Dis. 48, 1354–1360 (2009).
 33. Wang, Z. et al. Molecular characteristics of ofloxacin mono-resistant Mycobacterium tuberculosis isolates from new and previously 
treated tuberculosis patients. J. Clin. Lab. Anal. 32, 20 (2018).
 34. Salvato, R. S. et al. First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil. Infect. Genet. 
Evol. https ://doi.org/10.1016/j.meegi d.2019.10412 7 (2019).
 35. Brynildsrud, O. B. et al. Global expansion of Mycobacterium tuberculosis lineage 4 shaped by colonial migration and local adapta-
tion. Sci. Adv. 4, eaat5869 (2018).
 36. Salvato, R. S. et al. Molecular characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from a high-burden 
tuberculosis state in Brazil. Epidemiol. Infect. 147, e216 (2019).
 37. Perdigão, J. et al. Clonal expansion across the seas as seen through CPLP-TB database: A joint effort in cataloguing Mycobacterium 
tuberculosis genetic diversity in Portuguese-speaking countries. Infect. Genet. Evol. https ://doi.org/10.1016/j.meegi d.2018.03.011 
(2018).
 38. Walker, T. M. et al. Assessment of Mycobacterium tuberculosis transmission in Oxfordshire, UK, 2007–12, with whole pathogen 
genome sequences: An observational study. Lancet Respir. Med. 2, 285–292 (2014).
 39. Bjorn-Mortensen, K. et al. Tracing Mycobacterium tuberculosis transmission by whole genome sequencing in a high incidence 
setting: A retrospective population-based study in East Greenland. Sci. Rep. 6, 1–8 (2016).
 40. Conceição, E. C. et al. Analysis of potential household transmission events of tuberculosis in the city of Belem, Brazil. Tuberculosis 
https ://doi.org/10.1016/j.tube.2018.09.011 (2018).
 41. DallaCosta, E. R. et al. Multidrug-resistant Mycobacterium tuberculosis of the Latin American Mediterranean Lineage, Wrongly 
Identified as Mycobacterium pinnipedii (Spoligotype International Type 863 [SIT863]), causing active tuberculosis in South Brazil. 
J. Clin. Microbiol. 53, 3805–3811 (2015).
 42. Sacchi, F. P. C. et al. Prisons as reservoir for community transmission of tuberculosis, Brazil. Emerg. Infect. Dis. 21, 452–455 (2015).
 43. Stucki, D. et al. Standard genotyping overestimates transmission of Mycobacterium tuberculosis among immigrants in a low-
incidence country. J. Clin. Microbiol. 54, 1862–1870 (2016).
 44. IBGE. IBGE cidades. https ://cidad es.ibge.gov.br/brasi l/panor ama (2020).
11
Vol.:(0123456789)
Scientific RepoRtS |        (2020) 10:12891  | https://doi.org/10.1038/s41598-020-69755-9
www.nature.com/scientificreports/
 45. Brasil. Ministério da Saúde. Ministério da Saúde. Departamento de Vigilância de Doenças Transmissíveis. Manual de Reco-
mendações para o Controle da Tuberculose no Brasil. (2019).
 46. van Soolingen, D., Hermans, P. W., de Haas, P. E., Soll, D. R. & van Embden, J. D. Occurrence and stability of insertion sequences 
in Mycobacterium tuberculosis complex strains: Evaluation of an insertion sequence-dependent DNA polymorphism as a tool in 
the epidemiology of tuberculosis. J. Clin. Microbiol. 29, 2578–2586 (1991).
 47. Scheffer, M. C. Influência de fatores de risco do paciente e de características de Mycobacterium tuberculosis no desfecho dos casos 
novos de tuberculose pulmonar tratados com esquema básico: Uma coorte prospectiva de dois anos na Grande Florianópolis/SC. 
PhD Thesis. UFSC (2017).
 48. Kozarewa, I. & Turner, D. J. High-throughput next generation sequencing. Genome Biol. 733, 20 (2011).
 49. Stone, N. E. et al. More than 50% of clostridium difficile isolates from pet dogs in Flagstaff, USA, carry toxigenic genotypes. 
PLoS One 11, 1–21 (2016).
 50. Bolger, A. M., Lohse, M. & Usadel, B. Genome analysis Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics 
30, 2114–2120 (2014).
 51. Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
 52. Cruz, L. M. et al. Qualimap: Evaluating next-generation sequencing alignment data. Bioinformatics 28, 2678–2679 (2012).
 53. Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Genome analysis Sambamba: Fast processing of NGS alignment 
formats. Bioinformatics 31, 2032–2034 (2015).
 54. Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff. Fly (Austin) 
6, 80–92 (2012).
 55. Phelan, J. E. et al. Integrating informatics tools and portable sequencing technology for rapid detection of resistance to anti-
tuberculous drugs. Genome Med. https ://doi.org/10.1186/s1307 3-019-0650-x (2019).
 56. Coll, F. et al. A robust SNP barcode for typing Mycobacterium tuberculosis complex strains. Nat. Commun. 5, 4–8 (2014).
 57. De Almeida, I. N. et al. Frequency of the Mycobacterium tuberculosis RDRio genotype and its association with multidrug-resistant 
tuberculosis. BMC Infect. Dis. 19, 556 (2019).
 58. Gouy, M., Guindon, S. & Gascuel, O. Sea view version 4: A multiplatform graphical user interface for sequence alignment and 
phylogenetic tree building. Mol. Biol. Evol. 27, 221–224 (2010).
 59. Francisco, A. P., Bugalho, M., Ramirez, M. & Carriço, J. A. Global optimal eBURST analysis of multilocus typing data using a 
graphic matroid approach. BMC Bioinform. 10, 152 (2009).
 60. Rosłanowski, A., Shelah, S. & Spinas, O. Nonproper products. Bull. Lond. Math. Soc. 44, 299–310 (2012).
Acknowledgements
The authors are grateful to TGen, C-Path and ReSeqTB for supporting whole genome sequencing and to Bra-
zilian Network of Tuberculosis Research (REDE-TB) for enabling this partnership. We would like to thank to 
Laboratory of Bacteriology of Tuberculosis from LACEN/SC for the support and infrastructure and to Centro 
de Desenvolvimento Científico e Tecnológico (CDCT)/CEVS/SES-RS for the infrastructure in bioinformatics 
analysis. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Supe-
rior—Brasil (CAPES), finance code: 001 and supported by Laboratory of Molecular Biology, Microbiology and 
Serology (LBMMS)-Federal University of Santa Catarina-UFSC.
Author contributions
M.V. and R.S.S. conducted the bioinformatic analysis, interpreted the results and wrote the first draft of the 
manuscript, M.C.S. designed the study, collected the clinical data, performed sample collection and processing 
and spoligotyping, M.A.S. assist in bioinformatic analysis, F.H.B. processed the samples, H.M.M. performed 
statistical analysis, T.F.M. helped with experimental assays, D.B.R. performed sample processing and cultures, 
J.P. bioinformatic analysis supervision, M.V., I.P., A.K., M.L.B. helped in the interpretation of the data, providing 
critical intellectual content and A.K., M.L.B. designed and supervised the study. All authors provided key edits, 
commented and approved the final version of the manuscript.
competing interests 
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https ://doi.org/10.1038/s4159 8-020-69755 -9.
Correspondence and requests for materials should be addressed to M.V. or R.S.S.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this license, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
